KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Short term Debt (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Short term Debt for 16 consecutive years, with $225.0 million as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 91.59% to $225.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $225.0 million through Dec 2025, down 91.59% year-over-year, with the annual reading at $225.0 million for FY2025, 91.59% down from the prior year.
  • Short term Debt hit $225.0 million in Q4 2025 for Bausch Health Companies, down from $579.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.7 billion in Q4 2024 to a low of $150.0 million in Q2 2022.
  • Historically, Short term Debt has averaged $596.7 million across 4 years, with a median of $450.0 million in 2023.
  • Biggest five-year swings in Short term Debt: surged 494.22% in 2024 and later tumbled 91.59% in 2025.
  • Year by year, Short term Debt stood at $432.0 million in 2022, then rose by 4.17% to $450.0 million in 2023, then soared by 494.22% to $2.7 billion in 2024, then crashed by 91.59% to $225.0 million in 2025.
  • Business Quant data shows Short term Debt for BHC at $225.0 million in Q4 2025, $579.0 million in Q3 2025, and $879.0 million in Q2 2025.